1. Home
  2. ERII vs CSTL Comparison

ERII vs CSTL Comparison

Compare ERII & CSTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Energy Recovery Inc.

ERII

Energy Recovery Inc.

HOLD

Current Price

$8.76

Market Cap

595.9M

Sector

Technology

ML Signal

HOLD

Logo Castle Biosciences Inc.

CSTL

Castle Biosciences Inc.

HOLD

Current Price

$23.99

Market Cap

640.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ERII
CSTL
Founded
1992
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Medical Specialities
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
595.9M
640.6M
IPO Year
2008
2019

Fundamental Metrics

Financial Performance
Metric
ERII
CSTL
Price
$8.76
$23.99
Analyst Decision
Buy
Strong Buy
Analyst Count
3
6
Target Price
$17.07
$45.50
AVG Volume (30 Days)
1.0M
308.4K
Earning Date
05-06-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
5.00
N/A
EPS
N/A
N/A
Revenue
$134,987,000.00
$344,229,000.00
Revenue This Year
N/A
$2.42
Revenue Next Year
$20.55
$12.69
P/E Ratio
N/A
N/A
Revenue Growth
N/A
3.66
52 Week Low
$7.83
$14.59
52 Week High
$18.31
$44.28

Technical Indicators

Market Signals
Indicator
ERII
CSTL
Relative Strength Index (RSI) 49.20 66.18
Support Level $8.14 $23.21
Resistance Level $11.58 $24.33
Average True Range (ATR) 0.47 0.87
MACD 0.11 0.39
Stochastic Oscillator 43.58 90.42

Price Performance

Historical Comparison
ERII
CSTL

About ERII Energy Recovery Inc.

Energy Recovery Inc designs and manufactures energy-saving technologies. The firm uses its proprietary pressure exchanger technology to help customers in multiple industries improve their operations and lower their emissions. Using its proprietary technology, it offers energy recovery devices, including pressure exchangers, pumps, and turbochargers, mainly used for seawater desalination and wastewater treatment. Additionally, the company is involved in the development of emerging technologies, such as the PX G1300 used in industrial and commercial refrigeration applications. The firm's reportable operating segments are: Water, which generates maximum revenue, and Emerging Technologies. Geographically, it generates maximum revenue from the Middle East, and the rest from other markets.

About CSTL Castle Biosciences Inc.

Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. The company derives revenues through the delivery of test reports for its molecular diagnostic tests.

Share on Social Networks: